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Hyperplasia of synovial membrane in rheumatoid arthritis (RA) is a critical pathological foundation for inducing articular
injury. The janus kinase and signal transducer and activator of transcription (Jak-STAT) pathway plays a critical role in synovial
membrane proliferation induced by platelet-derived growth factor (PDGF). To explore the anti-cell proliferation mechanism of
curcumol, a pure monomer extracted from Chinese medical plant zedoary rhizome, the changes of Jak2-STAT1/3 signal pathway-
related molecules in synoviocytes were observed in vitro. In this study, the ﬁbroblast-like synoviocytes (FLS) in patients with RA
were collected and cultured. The following parameters were measured: cell proliferation (WST-1 assay), cell cycles (ﬂuorescence-
activated cell sorting, FACS), STAT1 and STAT3 activities (electrophoretic mobility shift assay, EMSA), and the protein expressions
ofphosphorylatedJak2, STAT1,andSTAT3(Westernblot).ItwasshownthatcurcumolcouldinhibittheRA-FLSproliferationand
DNAsynthesisinducedbyPDGF-BBinadose-dependentmannerinvitro.ThetranscriptionfactorsactivitiesofSTAT1andSTAT3
were obviously elevated after PDGF-BB stimulation (P<0.05). Super-shift experiments identiﬁed the STAT1 or STAT3 proteins
in the complex. Furthermore, the diﬀerent concentration curcumol could downregulate the DNA binding activities of STAT1
and STAT3 (P<0.05) and inhibit the phosphorylation of Jak2 while it had no eﬀect on the protein expressions of STAT1 and
STAT3. Positive correlations were found between changes of cell proliferation and DNA-binding activities of STAT1 and STAT3,
respectively (P<0.01). In conclusion, curcumol might suppress the FLS proliferation and DNA synthesis induced by PDGF-
BB through attenuating Jak2 phosphorylation, downregulating STAT1 and STAT3 DNA-binding activities, which could provide
theoretical foundation for clinical treatment of RA.
1.Introduction
Rheumatoid arthritis (RA) is a chronic destructive disease
of the joints that is characterized by chronic proliferative
synovitis, inﬁltration of inﬂammatory cells into the synovial
tissue of joints, and cartilage destruction. Fibroblast-like
synoviocytes (FLS) and inﬂammatory cells, such as macro-
phagesandTcells,produceproinﬂammatorycytokines,such
as interleukin (IL)-1β and tumor necrosis factor-α,w h i c h
play key roles in the pathogenesis of RA [1]. In RA, the
synovial lining can expand from the normal 1–3 cells to 15
or more cells thickness because of the increased number of
synoviocytes. Considering the characteristics of RA synovial
t i s s u e ss u c ha sm a r k e dp r o l i f e r a t i o na n di n v a s i o nt oa d j a c e n t
tissues, comparisons with transformed or neoplastic tissue
are natural. RA synovial tissues or cells are not truly ma-
lignant, but they have many features of transformation,
denoted as “partial transformation”. These features include
anchorage-independent growth, loss of contact inhibition,
oncogene activation, monoclonal or oligoclonal expansion,
detectable telomerase activity, and somatic gene mutations
[2, 3]. Therefore, therapies used in the treatment of tumors
may be eﬀective in the treatment of RA. Clinical experience
shows that RA treatment may be more eﬀective than simple2 Evidence-Based Complementary and Alternative Medicine
anti-inﬂammatory therapy if synoviocyte proliferation and
pannus production can be suppressed, and apoptosis can
be promoted. Pulse therapy of small doses of methotrexate
is the gold standard of RA treatment [4]. Therefore, it is
of significance to screen eﬀective ingredients from natu-
ral antitumor drugs and investigate their eﬀects on synov-
iocyte proliferation and intrinsic mechanisms involved in
RA.
Rhizoma Curcumae (rhizome of Curcuma; Ezhu in
Chinese)isatraditionalChinesemedicinethathasbeenused
in removing blood stasis and alleviating pain for over a thou-
sandyearsinChina.Theessentialoilsareconsideredasactive
constituents in Rhizoma Curcumae, which include curdione,
curcumol, and germacrone. Curcumol is one of the major
components of the essential oil of Rhizoma Curcumae with
the structure of a guaiane-type sesquiterpenoid hemiketal. It
exhibits characteristics such as antitumor, antiproliferation,
anti-inﬂammatory, anti-hepatic ﬁbrosis, antioxidant, and
antimicrobial activities with low cytotoxicity [5–8]. The pro-
liferation and RNA synthesis of tumor cell lines derived from
female patients including MCF7, MM231, HeLa, and OV-
UL-2 were inhibited by curcumol in vitro [9]. It was shown
that curcumol induced cell death in a dominant apoptotic
fashionviathecaspases-independentmitochondrialpathway
in ASTC-a-1 cells [10]. However, little is known about
the characteristics and molecular mechanism of curcumol-
induced antiproliferation eﬀect.
In this experiment, we treated synoviocytes of RA with
curcumol in vitro and evaluated the cytotoxic eﬀects of cur-
cumol on cell viability, cell cycle arrest, signal transducer and
activator of transcription (STAT) 1 and STAT3 activities, and
protein expressions of phosphorylated Janus kinase (Jak) 2,
STAT1, and STAT3. The aim of the study is to explore the
eﬀect and mechanism of curcumol on inhibiting cell prolif-
eration at the level of Jak2-STAT signal transduction induced
by platelet-derived growth factor (PDGF)-BB.
2.MaterialsandMethods
2.1. Materials. Curcumol (C15H24O2) was separated from
Curcuma Turmeric Oil (vapor distillated from Rhizoma
Curcumae) combining crystal precipitation in lower temper-
ature (0–5◦C) with anhydrous ethanol recrystallization and
characterized by chromatography with curcumol reference
substance (obtained from National Institute for the Control
of Pharmaceutical and Biological Products, batch number:
CUL081007T, used for assay). The purity of curcumol was
greater than 98% by the peak normalization method using
HPLC-UV. Working solutions were prepared by dissolving
the compound in ethanol before the experiments. Human
PDGF-BB was purchased from PeproTech (NJ, USA). WST-
1 Cell Proliferation and Cytotoxicity Assay Kit was obtained
from KeyGEN (Nanjing, China). Rabbit anti-phospho-Jak2
(Tyr1007/1008), anti-STAT3 polyclonal antibodies were pur-
chasedfromBiovision(CA,USA).Mouseanti-STAT1mono-
clonal antibodies were obtained from BioLegend (CA, USA).
LightShift Chemiluminescent EMSA Kit was purchased from
Pierce (IL, USA).
2.2. Isolation and Culture of Human FLS. The human FLS
were isolated from primary synovial tissue obtained from
three patients with RA who met the revised American
Rheumatism Association criteria [11] and had undergone
total joint replacement surgery or synovectomy, as described
previously [12]. Brieﬂy, fresh synovial tissues were minced
and digested with 0.5mg/mL of type I collagenase (Sigma-
Aldrich, St. Louis, MO, USA) by shaking vigorously at 37◦C
for 4h. The supernatant containing the released cells was
then removed, and the digestion procedure was repeated two
times. Cells were used at passages 4–8, at which time they
were comprised of a homogeneous population. Cells were
grown at 37◦C under a humidiﬁed, 5% CO2 atmosphere
in high glucose-containing Dulbecco’s modiﬁed eagle’s me-
dium (DMEM) (Gibco BRL, Grand Island, NY) supple-
mented with 10% fetal bovine serum, 2mmol/L glutamine,
100units/mL of penicillin, and 100μg/mL of streptomycin.
The study was approved by the Southwest hospital Ethical
Committee, and all participants gave written informed con-
sent to their participation.
About 1 × 104 viable cells were added to each well of 96-
well cell culture plate for cell proliferation assay, and 1 × 106
cells added to each well of six-well culture plate for the
other detections. Cells were randomly divided into several
groups: normal control group (normal FLS), PDGF-BB
group (25ng/mL PDGF-BB for 30min), and the remaining
groups were treated with diﬀerent concentrations of curcu-
mol preinduced by PDGF-BB for 30min. Curcumol was ﬁrst
dissolved in absolute ethanol, and the resulting solution was
dilutedwiththemediumtovariousconcentrations.Theﬁnal
concentration of absolute ethanol should not exceed 1% of
thetotalculturevolume.Asolventcontrolgroup(containing
PDGF-BB and 1% absolute ethanol without curcumol) was
applied in cell cycle detection. Then, the plate was incubated
at 37◦Ci na5 %C O 2 atmosphere for 24h. Cellular nuclear
and cytoplasmic proteins were obtained in corresponding
methods.
2.3. Cell Proliferation Assay. The FLS were added to each
well of 96-well cell culture plate and incubated overnight
at 37◦C under 5% CO2 in a humidiﬁed incubator to allow
cells to attach to wells. Then, cells were treated with PDGF-
BB and diﬀerent concentrations (25, 50, 100, 200, 400, and
800μg/mL) of curcumol for 24h, and the eﬀect of curcumol
on the proliferation of cells was determined by WST-
1 (4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-
1,3-benzene disulfonate) assay according to the manufac-
turer’s instructions [13, 14].
2.4. Cell Cycle Determination. Cell cycle distribution was
analyzed using ﬂuorescence-activated cell sorting (FACS).
Brieﬂy, after being induced by PDGF-BB and treated with
diﬀerent concentrations (25, 50, 100μg/mL) of curcumol
for 24h, the cells in six-well plate were harvested, washed
twice with PBS, and ﬁxed in 70% ethanol at 4◦Cf o r1ha n d
centrifuged. The pellet was treated with RNase (20mg/mL)
at room temperature for 30min and then incubated with
propidium iodide (50mg/mL) for 30min [10].Evidence-Based Complementary and Alternative Medicine 3
2.5. Cell Extracts. T h eF L Si ns i x - w e l lp l a t ew e r et r e a t e dw i t h
diﬀerent concentrations (25, 50, 100μg / m L )o fc u r c u m o l ,
and nuclear extracts were prepared by a modiﬁcation of
the methods [15, 16]. Supernatants of cells in culture plate
were discarded, and cells were washed three times in cold
phosphate-buﬀered saline (PBS). Nonadherent cells were
pelleted and resuspended in 1.5mL cold PBS. The cells
were pelleted for 10s and resuspended in 100μLc o l dB u ﬀer
A (10mmol/L HEPES–NaOH (pH 7.8), 15mmol/L KCl,
1mmol/L MgCl2, 0.1mmol/L EDTA, 1mmol/L dithiothre-
itol,1mmol/LPMSF,and1mg/mLleupeptin)byﬂickingthe
tube. The cells were allowed to swell on ice for 15min and
then vortexed for 10s by adding 10% NP-40 10μL. Samples
were centrifuged for 30s. The pellet was resuspended in
50μLo fc o l dB u ﬀer B (20mmol/L HEPES-NaOH (pH 7.9),
1.5mmol/L MgCl2, 0.42mol/L NaCl, 0.2mmol/L EDTA,
25% glycerol, 0.5mmol/L dithiothreitol, 0.5mmol/L PMSF,
and 1mg/mL leupeptin) and incubated on ice for 30min
for high-salt extraction. Cellular debris was removed by
centrifugation for 1min at 12,000 × g, and the supernatant
fraction (containing DNA-binding proteins) was stored at
−70◦C. Protein concentrations were determined by Brad-
ford’s method [17].
2.6. Electrophoretic Mobility Shift Assay (EMSA) for STAT1
and STAT3 Activities. The assay is based on that DNA-
protein complexes migrate slower than unbound DNA or
double-stranded oligonucleotides in a native polyacrylamide
or agarose gel, resulting in a “shift” in migration of the la-
beled DNA band. The detection of bands was by “The Light-
Shift Chemiluminescent EMSA kit” that uses a nonisotopic
method to detect DNA-protein interactions. Two double-
stranded oligonucleotides containing human STAT1 site (P1:
5 -CAT GTT ATG CAT ATT CCT GTA AGT-3 ;P 2 :5  -
ACT TAC AGG AAT ATG CAT AAC ATG -3 )a n dS T A T 3
site (P1: 5 -GAT CCT TCT GGG AAT TCC TAG ATC-3 ;
P2: 5 -GAT CTA GGA ATT CCC AGA AGG ATC-3 )w e r e
end-labeled with biotin. Binding assays were performed in
21μL of binding reaction mixture containing 3μgn u c l e a r
extract protein, DNA-binding buﬀer and 40 fmol biotin-
labeled DNA probe. For super-shift assays, the extracts were
incubated ﬁrst with the STAT1 or STAT3 antibodies for
20min followed by the addition of the corresponding biotin
probe. Reactions were incubated at room temperature for
30min and analyzed by electrophoresis on a 12% nonde-
naturing polyacrylamide gel at 200V for 1.5h using the
high ionic strength conditions. The speciﬁcity of binding
was conﬁrmed by addition of a 200-fold excess of unlabeled
double-stranded oligonucleotides containing human STAT1
or STAT3 site to separate reaction mixtures, respectively. As
an additional control, a 200-fold excess of cold oligonucleo-
tide bearing the NF-κB binding site was added to separate
reaction mixtures. Competition reactions were incubated
for 10min before addition of labeled oligonucleotide. After
transfer the membrane was immediately cross-linked for
15min on a UV transilluminator equipped with 312nm
bulbs. A chemiluminescent detection method utilizing a
luminol/enhancer solution and a stable peroxide solution
(Pierce, USA) was used as described by the manufacturer,
andmembraneswereexposedtoX-rayﬁlmsfor2minbefore
developing. The bands were scanned, and relative intensities
were analyzed by Labwork Analysis Software [18, 19].
2.7. Western Blot for Protein Expressions of Phosphorylated
Jak2 (p-Jak2), STAT1, and STAT3. The FLS in six-well
plate were treated with curcumol at the concentrations of
25μg/mL and 50μg/mL and lysed in lysis buﬀer containing
1% Triton X-100, 50mmol/L HEPES, pH 7.5, 10% glycerol,
150mmol/L NaCl, 1.5mmol/L EGTA, 10mmol/L sodium
pyrophosphate, 100mmol/L NaF, 2mmol/L sodium ortho-
vanadate, 10μg/mL aprotinin, and 1mmol/L phenylmethyl-
sulfonylﬂuoride. Lysates were cleared by centrifugation at
13,000 × g for 15min at 4◦C. After lysis, protein content
was quantiﬁed by Bradford’s method. Equal amounts of
p r o t e i nw e r el o a d e do ne a c hl a n eo faS D S - P A G E( s o d i u m
dodecyl sulfate polyacrylamide gel electrophoresis) gel and
transferred to polyvinylidene ﬂuoride membrane (PVDF)
in 25mmol/L Tris, 192mmol/L glycine, 20% methanol at
80mA for 4h. The ﬁlters were blocked to reduce nonspeciﬁc
binding by incubation in blocking buﬀer (3% nonfat milk,
0.01M PBS, 0.02% Tween-20) overnight. The blots were
then incubated with rabbit polyclonal antiphosphorylated
Jak2 or STAT1 or STAT3 antibody at 1:1000 dilution for
1h, respectively. After being washed with PBS-Tween-20, the
blots were incubated with secondary antibody conjugated
to horseradish peroxidase blocking buﬀer for 1h. The blots
were washed extensively with PBS-Tween-20 and developed
by the enhanced chemiluminescence (ECL) methods (Pierce,
USA) and then exposed to X-ray ﬁlm for 2min. The protein
signals were quantiﬁed by an image-scanning densitometer,
and the strength of each protein signal was normalized to the
corresponding β-actin stain signal [20].
2.8. Statistics. The data were presented as mean ± stand-
ard deviations (S.D). Statistical analysis was evaluated by
Student’s t-test (between normal control and PDGF-BB
group)orone-way(betweenPDGF-BBanddrugtreatments)
ANOVA followed by Dunnett’s t-test for multiple compari-
sons using SPSS statistical program. A level of P<0.05 was
considered statistically signiﬁcant.
3. Results
3.1. Eﬀect of Diﬀerent Concentrations of Curcumol on Cell
Proliferation and DNA Synthesis in FLS from Patients with
RA. Compared to the PDGF-BB group, cell proliferation
and DNA synthesis of FLS changed very signiﬁcantly in the
groups treated with curcumol (P<0.01). With the curcumol
concentration increasing, the OD value decreased gradually,
indicating various degrees of cell proliferation suppression.
The inhibitory rate (%) was calculated by the equation:
inhibitory rate (%) = ODstimulation−ODcurcumol/ODstimulation.
The data showed that with the curcumol concentration
increasing (25–800μg/mL), the inhibitory rate of syn-
oviocyte proliferation increased gradually (8.15%, 11.47%,
13.17%, 15.00%, 15.33%, and 36.37%), respectively. We
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Figure 1: Inhibitory eﬀect of diﬀerent concentration curcumol on
FLS proliferation in patients with RA. 1: normal control; 2: PDGF-
BB; 3: curcumol 25μg / m L ;4 :c u r c u m o l5 0 μg/mL; 5: curcumol
100μg/mL; 6: curcumol 200μg / m L ;7 :c u r c u m o l4 0 0μg/mL; 8: cur-
cumol 800μg/mL. Data are expressed as mean ± SD of triplicates.
#P<0.05, ##P<0.01, compared with normal control. ∗P<0.05,
∗∗P<0.01, compared with PDGF-BB.
distribution of cells in G1, G2, and S. It was shown that
PDGF-BBstimulationenhancedDNAsynthesiscomparedto
thenormalcontrolgroup(52.49%versus13.87%).TheDNA
synthesis was not signiﬁcantly diﬀerent between the PDGF-
BB and solvent control group. With the increasing concen-
trations of curcumol, the ratio of cells at S phase gradually
decreased from 35.76%, 28.74% to 14.52%, demonstrating
that curcumol suppressed DNA synthesis of synoviocytes
in a concentration-dependent manner. These data showed
that various concentrations of curcumol suppressed syn-
oviocyte proliferation and DNA synthesis (Figure 1 and
Figure 2). Based on data from preliminary studies, three
diﬀerent concentrations of curcumol (25μg/mL, 50μg/mL,
and 100μg/mL) were chosen for the following experi-
ments.
3.2. Eﬀect of Diﬀerent Concentrations of Curcumol on STAT1
and STAT3 Activities in FLS from Patients with RA. The spec-
iﬁcityoftheshiftbandsinEMSAwasveriﬁedbycompetition
assays: all the shift bands were suppressed by incubation
with a 200-fold excess of unlabeled STAT1 or STAT3 probe
and unchanged by competition with a similar amount of
another irrelevant oligonucleotide such as NF-κB (data not
shown). In absence of stimulation, STAT1 and STAT3 DNA-
binding activitiesofRAsynoviocytewereweakinthenormal
control group. Following stimulation with 25ng/mL PDGF-
BB, STAT1 and STAT3 activities increased signiﬁcantly
(P<0.05). After treatment with various concentrations of
curcumol (25μg/mL, 50μg/mL, 100μg/mL), STAT1 activity
decreased (P<0.05), and STAT3 activity was suppressed
very signiﬁcantly (P<0.01). In addition, STAT1 and STAT3
antibody super-shift assays showed that the binding bands
lagged obviously after addition of STAT1 or STAT3 antibod-
ies, demonstrating the presence of STAT1 or STAT3 proteins
in the binding bands (DNA-protein complexes) (Table 1,
Figures 3 and 4). Positive correlations were found between




































Figure 2: Inhibitory eﬀect of diﬀerent concentration curcumol
on FLS DNA synthesis in patients with RA. 1: normal control; 2:
PDGF-BB; 3: solvent control; 4: curcumol 25μg/mL; 5: curcumol
50μg/mL; 6: curcumol 100μg/mL. Data are expressed as mean ±
SD of triplicates. #P<0.05, ##P<0.01, compared with normal
control. ∗P<0.05, ∗∗P<0.01, compared with PDGF-BB.
of STAT1 and STAT3 following diﬀerent concentrations of
curcumol (r = 0.948, P = 0.007; r = 0.941, P = 0.009),
respectively.
3.3. Eﬀect of Diﬀerent Concentrations of Curcumol on the Pro-
tein Expression of p-Jak2, STAT1, and STAT3 in FLS. Western
blot analysis showed that p-Jak2 protein was activated in
RA synoviocytes and slightly increased following stimulation
with 25ng/mL PDGF-BB (P = 0.053). The protein expres-
sions of STAT1 and STAT3 upregulated signiﬁcantly after
PDGF-BB stimulation compared to normal control (P =
0.005; P = 0.011), respectively. Following treatment with
curcumol at the concentration of 50μg/mL, there were no
obvious changes in STAT1 and STAT3 protein expressions
(P>0.05) while the phosphorylation of Jak2 was suppressed
very signiﬁcantly (P = 0.001) (Table 2 and Figure 5).
4. Discussion
Curcumol is an eﬀective anticancer drug used in traditional
Chinese medicine. As a potent strategy to protect against
carcinogenesis, phytochemicals in Chinese medicine herbs
have been applied to protect against carcinogenesis through
acting on diverse cellular events including regulation of
apoptosis [21]. Curcumol inhibited the proliferation and
RNA synthesis of tumor cells (MCF7, MM231, HeLa, and
OV-UL-2) in vitro while it had no eﬀect on normal mamma-
ry gland cells [9]. It has been conﬁrmed that in vitro cultured
type B synoviocytes from RA patients express oncogenes
that are characteristics of actively dividing cells. Hence, the
growth of synoviocytes from RA patients is out of control,
resulting in excessive proliferation of synovial membrane
and pannus invasion [2]. Therefore, RA treatment may refer
to method of tumor therapy. Our data demonstrated that
certain concentration curcumol ranging from 25μg/mL to
100μg/mL could inhibit the RA-FLS proliferation and DNA
synthesis induced by PDGF-BB in vitro, which showed thatEvidence-Based Complementary and Alternative Medicine 5
Table 1: Eﬀect of diﬀerent concentrations of curcumol on STAT1 and STAT3 activities in FLS from patients with RA.
Groups STAT DNA-binding activities
STAT1 STAT3
Lane 2 (normal control) 168.75 ±58.54 176.50 ± 25.51
Lane 3 (PDGF-BB 25ng/mL) 296.75 ±72.96# 344.50 ±50.98#
Lane 4 (curcumol 25μg/mL) 90.65 ±14.94∗ 116.38 ±17.81∗∗
Lane 5 (curcumol 50μg/mL) 109.13 ±11.86∗ 96.38 ± 23.24∗∗
Lane 6 (curcumol 100μg/mL) 87.38 ±13.24∗ 81.38 ± 15.56∗∗
Each value represents the mean ± S.D. for three independent experiments. ∗P<0.05 versus PDGF-BB. ∗∗P<0.01 versus PDGF-BB (Dunnett’s t-test). #P<
0.05 versus normal control (Student’s t-test); one-way ANOVA revealed signiﬁcant eﬀects between PDGF-BB and drug treatment groups (F = 27.823, P =
0.000 for STAT1, F = 66.587, P = 0.000 for STAT3).
12345678
Figure 3: Curcumol inhibited STAT1 DNA-binding activity in FLS
from patients with RA. Representative picture of three experiments
of EMSA. Lane 1: negative control; lane 2: normal control; lane 3:
PDGF-BB; lane 4: curcumol 25μg / m L ;l a n e5 :c u r c u m o l5 0μg/mL;
lane 6: curcumol 100μg/mL; lane 7: IgG control; lane 8: STAT1
antibody.
curcumol might be one of candidate drugs for treating
RA.
The janus kinases (Jaks) have generated great interest in
recent years as therapeutic targets due to the unique role that
these enzymes play as gatekeepers in the signal transduction
process [22–24]. Named after the Roman god of gates and
doors (“Janus”), these four enzymes (Jak1, Jak2, Jak3, and
Tyk2) control signaling of numerous cytokines and therefore
play a central role in acquired and innate immunity and
hematopoiesis [25]. The Jak-STAT pathway is the signaling
target of a multitude of cytokines, including interferon-γ,IL -
2, IL-4, IL-6, IL-7, IL-10, IL-12, and IL-15, all of which are
thought to have biologically signiﬁcant roles in rheumatoid
synovial inﬂammation [26, 27]. Seven STATs have been
identiﬁed, and preliminary work in human synovial tissue
suggests that STAT1 expression and activity are increased
in RA synovium and STAT3 promotes survival of RA
synovial ﬁbroblasts [28–30]. SOCS (suppressors of cytokine
signaling) are inhibitory factors in the negative-feedback
12345678
Figure 4: Curcumol inhibited STAT3 DNA-binding activity in FLS
from patients with RA. Representative picture of three experiments
of EMSA. Lane 1: negative control; lane 2: normal control; lane 3:
PDGF-BB; lane 4: curcumol 25μg / m L ;l a n e5 :c u r c u m o l5 0μg/mL;
lane 6: curcumol 100μg/mL; lane 7: IgG control; lane 8: STAT3
antibody.
regulation of Jak-STAT signal pathway [31]. Using retroviral-
mediated gene transfer of a dominant negative mutant of
Stat3, termed Stat3-YF, it was found that overexpression of
Stat3-YF eﬀectively blocked endogenous Stat3 activation and
Stat3-dependentgeneexpression,includingexpressionofthe
socs3 and myc genes. Stat3-YF-transduced RA synoviocytes
failed to grow in culture, exhibited markedly diminished
[3H] thymidine incorporation, and died spontaneously [30].
These ﬁndings demonstrate that STAT1 and STAT3 activa-
tion plays an important role in synoviocyte proliferation.
In addition, PDGF-BB is one of disulphide-bonded dimeric
PDGF isoforms and consists of four polypeptide chains.
PDGF receptor (PDGF-R), in turn, may occur as α or
β homodimers or as α/β heterodimers [32]. The binding
of the dimeric ligand to the extracellular portions of the
two PDGF-R chains elicits the dimerization of PDGF-Rs
and the autophosphorylation of their cytoplasmic tyrosine
residues. Receptors for PDGF are abundantly expressed
on synoviocytes from patients with RA, and stimulation
with PDGF enhances both the anchorage-dependent and6 Evidence-Based Complementary and Alternative Medicine
Table 2: Eﬀect of diﬀerent concentrations of curcumol on p-Jak2, STAT1, and STAT3 in FLS from patients with RA.
Groups
Normalized density (target protein/β-actin)
p-Jak2 STAT1 STAT3
Lane 1 (normal control) 0.3282 ±0.0123 0.1395 ±0.0009 0.2031 ±0.0361
Lane 2 (PDGF-BB
25ng/mL) 0.3886 ±0.0170 0.3144 ±0.0117## 0.3152 ±0.0240#
Lane 3 (curcumol
25μg/mL) 0.2042 ±0.0416 0.4055 ±0.0865 0.2463 ±0.0856
Lane 4 (curcumol
50μg/mL) 0.1128 ±0.0125∗∗ 0.3510 ±0.0163 0.3909 ±0.0546
Each value represents the mean ± S.D. for three independent experiments. ∗P<0.05 versus PDGF-BB. ∗∗P<0.01 versus PDGF-BB (Dunnett’s t-test). #P<
0.05 versus normal control. ##P<0.05 versus normal control (Student’s t-test); one-way ANOVA revealed insigniﬁcant eﬀects between PDGF-BB and drug

















the STAT1 and STAT3 protein expression in FLS from patients with
RA was not inhibited by curcumol. Representative picture of three
experiments of western blot. Lane 1: normal control; lane 2: PDGF-
BB; lane 3: curcumol 25μg/mL; lane 4: curcumol 50μg/mL.
-independent growth of synoviocytes. In synovial membrane
of RA, synoviocytes, neutrophils, and macrophages produce
large amounts of PDGF, leading to cytoplasmic Jak2 tyrosine
phosphorylation and STAT1, STAT3 nuclear protein activa-
tion through binding to membrane PDGF-R [33, 34]. The
present study showed that the transcription factors activities
of STAT1 and STAT3 were obviously elevated after PDGF-BB
stimulation (P<0.05). Super-shift experiments identiﬁed
the proteins STAT1 or STAT3 in the complex. Additional
treatment with curcumol inhibited the phosphorylation of
Jak2 and reduced the DNA-binding activities of STAT1
and STAT3. Furthermore, positive correlations were found
between changes of cell proliferation and activities of STAT1
and STAT3 (P<0.01). Accordingly, Jak2-STAT1/3 signal
pathway might be the upstream mechanism of the inhibitory
eﬀect of curcumol on cell proliferation.
In summary, the potential antiproliferation of curcumol
against RA-FLS has been investigated. These results demon-
strate for the ﬁrst time that curcumol might suppress the
FLS proliferation and DNA synthesis induced by PDGF-BB
through attenuating Jak2 phosphorylation, downregulating
STAT1 and STAT3 DNA-binding activities. Although further
work is needed to clarify the complicated mechanism of cur-
cumol-induced antiproliferation, curcumol is very promis-
ing as a new potential agent for clinical treatment of RA.
At present, diﬀerent concentrations of curcumol were
applied to explore their corresponding mechanisms in vitro
[6, 9, 10]. There is no literature related to human application
in vivo, so it is still unknown about curcumol concentrations
obtainable in patients. Signal transduction is a biochemical
event by which cells transmit a signal from the cell exterior
through the cell membrane and into the cytoplasm. Cell
proliferation induced by diﬀerent cytokines involves many
related signal molecules, including receptors, kinases, and
secondary messengers [35].Therefore, it is necessary to fur-
ther explore the eﬀects of curcumol on FLS proliferation in-
duced by other cytokines (tumor necrosis factor-alpha, basic
ﬁbroblast growth factor, and transforming growth factor-
beta) in the future.
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